Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method

Medical Microbiology and Immunology

Volumn 198, Issue 4, 2009, Pages 257-262

  Ogbomo, Henry ^a   Geiler, Janina ^a   Leutz, Anke ^a   Von Kietzell, Kristina ^a   Michaelis, Martin ^a   Doerr, Hans Wilhelm ^a   Cinatl Jr , Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Coupled luminescent method; Cytotoxic T lymphocytes; Cytotoxicity; Dendritic cells; HLA A2 restricted peptide; Human cytomegalovirus

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1;

ARTICLE; CONTROLLED STUDY; COUPLED LUMINESCENT METHOD; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INTERMETHOD COMPARISON; LUMINESCENCE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; HLA-A2 ANTIGEN; HUMANS; LUMINESCENT MEASUREMENTS; LYMPHOCYTE ACTIVATION; PHOSPHOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 70350614303     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0126-5     Document Type: Article

References (39)

1. KT Brunner J Mauel JC Cerottini B Chapuis 1968 Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs Immunology 14 181 196 1:CAS:528:DyaF1cXhtVens7o%3D 4966657
2. P von Zons P Crowley-Nowick D Friberg M Bell U Koldovsky TL Whiteside 1997 Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma Clin Diagn Lab Immunol 4 202 207
3. C Granberg K Blomberg I Hemmila T Lovgren 1988 Determination of cytotoxic T lymphocyte activity by time-resolved fluorometry using europium-labelled concanavalin A-stimulated cells as targets J Immunol Methods 114 191 195 10.1016/0022-1759(88)90173-1 1:STN:280:DyaL1M%2FjsFGluw%3D%3D 2972782 (Pubitemid 18260027)
4. K Blomberg C Granberg I Hemmila T Lovgren 1986 Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence J Immunol Methods 86 225 229 10.1016/0022-1759(86)90457-6 1:STN:280:DyaL287htlCktA%3D%3D 3456003 (Pubitemid 16146649)
5. K Blomberg C Granberg I Hemmila T Lovgren 1986 Europium-labelled target cells in an assay of natural killer cell activity. II. A novel non-radioactive method based on time-resolved fluorescence. significance and specificity of the method J Immunol Methods 92 117 123 10.1016/0022-1759(86)90511-9 1:CAS:528:DyaL28XltlWksLo%3D 3745921 (Pubitemid 16051388)
6. SY Zimmermann R Esser E Rohrbach T Klingebiel U Koehl 2005 A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells J Immunol Methods 296 63 76 10.1016/j.jim.2004.10.014 1:CAS:528:DC%2BD2MXntVSisg%3D%3D 15680151 (Pubitemid 40174740)
7. H Ogbomo A Hahn J Geiler M Michaelis HW Doerr J Cinatl Jr 2006 NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method Biochem Biophys Res Commun 339 375 379 10.1016/j.bbrc.2005. 11.025 1:CAS:528:DC%2BD2MXht1Ortr%2FM 16297863 (Pubitemid 41697560)
8. H Ogbomo M Michaelis J Kreuter HW Doerr J Cinatl Jr 2007 Histone deacetylase inhibitors suppress natural killer cell cytolytic activity FEBS Lett 581 1317 1322 10.1016/j.febslet.2007.02.045 1:CAS:528:DC%2BD2sXjsVWnsrk%3D 17349632 (Pubitemid 46452605)
9. H Asanuma M Sharp HT Maecker VC Maino AM Arvin 2000 Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression J Infect Dis 181 859 866 10.1086/315347 1:CAS:528:DC%2BD3cXivVOgtbk%3D 10720505 (Pubitemid 30194466)
10. N Khan A Hislop N Gudgeon M Cobbold R Khanna L Nayak AB Rickinson PA Moss 2004 Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection J Immunol 173 7481 7489 1:CAS:528:DC%2BD2cXhtVCqurrJ 15585874
11. M Provenzano S Mocellin M Bettinotti J Preuss V Monsurro FM Marincola D Stroncek 2002 Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells J Immunother 25 342 351 10.1097/00002371-200207000-00006 1:CAS:528:DC%2BD38Xms1Shs7k%3D 12142557 (Pubitemid 34857289)
12. MR Wills AJ Carmichael K Mynard X Jin MP Weekes B Plachter JG Sissons 1996 The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp 65-specific CTL J Virol 70 7569 7579 1:CAS:528: DyaK28Xmt1GltL0%3D 8892876
13. E McLaughlin-Taylor H Pande SJ Forman B Tanamachi CR Li JA Zaia PD Greenberg SR Riddell 1994 Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes J Med Virol 43 103 110 10.1002/jmv.1890430119 1:CAS:528: DyaK2cXksFGnt7Y%3D 8083644
14. F Kern T Bunde N Faulhaber F Kiecker E Khatamzas IM Rudawski A Pruss JW Gratama R Volkmer-Engert R Ewert P Reinke HD Volk LJ Picker 2002 Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals J Infect Dis 185 1709 1716 10.1086/340637 1:CAS:528:DC%2BD38Xlt1Cksb0%3D 12085315 (Pubitemid 34615463)
15. GA Papanicolaou JB Latouche C Tan J Dupont J Stiles EG Pamer M Sadelain 2003 Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele Blood 102 2498 2505 10.1182/blood-2003-02-0345 1:CAS:528:DC%2BD3sXnslyktb0%3D 12805061 (Pubitemid 37193588)
16. SB Boppana WJ Britt 1996 Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells Virology 222 293 296 10.1006/viro.1996.0424 1:CAS:528:DyaK28XkvVCgsLg%3D 8806513 (Pubitemid 26281385)
17. SR Riddell M Rabin AP Geballe WJ Britt PD Greenberg 1991 Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression J Immunol 146 2795 2804 1:CAS:528:DyaK3MXltlers7Y%3D 1707922
18. MJ Gilbert SR Riddell CR Li PD Greenberg 1993 Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus J Virol 67 3461 3469 1:CAS:528:DyaK3sXkvFensLY%3D 8388509
19. SR Riddell PD Greenberg 1994 Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones Curr Top Microbiol Immunol 189 9 34 1:STN:280:DyaK2M%2FgvV2huw%3D%3D 7924439
20. DJ Diamond J York JY Sun CL Wright SJ Forman 1997 Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection Blood 90 1751 1767 1:CAS:528:DyaK2sXls1GisLs%3D 9292508
21. K Falk O Rotzschke K Deres J Metzger G Jung HG Rammensee 1991 Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast J Exp Med 174 425 434 10.1084/jem.174.2.425 1:CAS:528: DyaK3MXltlelsr4%3D 1713253
22. K Falk O Rotzschke S Stevanovic G Jung HG Rammensee 1991 Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules Nature 351 290 296 10.1038/351290a0 1:CAS:528:DyaK3MXkt1Ogs78%3D 1709722
23. HG Rammensee K Falk O Rotzschke 1993 Peptides naturally presented by MHC class I molecules Annu Rev Immunol 11 213 244 10.1146/annurev.iy.11.040193. 001241 1:CAS:528:DyaK3sXktVKmu7g%3D 8476560
24. DF Hunt RA Henderson J Shabanowitz K Sakaguchi H Michel N Sevilir AL Cox E Appella VH Engelhard 1992 Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry Science 255 1261 1263 10.1126/science.1546328 1:CAS:528:DyaK38XhvFahsr0%3D 1546328
25. DB Crumpacker J Alexander P Cresswell VH Engelhard 1992 Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2 J Immunol 148 3004 3011 1:CAS:528:DyaK38Xkt1CnsLo%3D 1374446
26. HT Maecker SA Ghanekar MA Suni XS He LJ Picker VC Maino 2001 Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens J Immunol 166 7268 7275 1:CAS:528:DC%2BD3MXksVOnurg%3D 11390476
27. SA Ghanekar LE Nomura MA Suni LJ Picker HT Maecker VC Maino 2001 Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65 Clin Diagn Lab Immunol 8 628 631 1:CAS:528: DC%2BD3MXktVOmsL0%3D 11329470
28. M Engstrand AK Lidehall TH Totterman B Herrman BM Eriksson O Korsgren 2003 Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment Clin Exp Immunol 132 96 104 10.1046/j.1365-2249.2003.02098.x 1:CAS:528:DC%2BD3sXjtlKrsLo%3D 12653843 (Pubitemid 36418912)
29. EC Waller E Day JG Sissons MR Wills 2008 Dynamics of T cell memory in human cytomegalovirus infection Med Microbiol Immunol 197 83 96 10.1007/s00430-008-0082-5 18301918
30. H Martin M Mandron C Davrinche 2008 Interplay between human cytomegalovirus and dendritic cells in T cell activation Med Microbiol Immunol 197 179 184 10.1007/s00430-008-0079-0 18264717
31. K Besold B Plachter 2008 Recombinant viruses as tools to study human cytomegalovirus immune modulation Med Microbiol Immunol 197 215 222 10.1007/s00430-008-0083-4 18301917
32. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 245 252 10.1038/32588 1:CAS:528:DyaK1cXitFWrsr8%3D 9521319 (Pubitemid 28155090)
33. MV Dhodapkar RM Steinman M Sapp H Desai C Fossella J Krasovsky SM Donahoe PR Dunbar V Cerundolo DF Nixon N Bhardwaj 1999 Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells J Clin Invest 104 173 180 10.1172/JCI6909 1:CAS:528:DyaK1MXkslSmsbo%3D 10411546
34. MJ Corey RJ Kinders LG Brown RL Vessella 1997 A very sensitive coupled luminescent assay for cytotoxicity and complement-mediated lysis J Immunol Methods 207 43 51 10.1016/S0022-1759(97)00098-7 1:CAS:528:DyaK2sXlsFGlsr0%3D 9328585 (Pubitemid 27400471)
35. L Jenne JF Arrighi H Jonuleit JH Saurat C Hauser 2000 Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis Cancer Res 60 4446 4452 1:CAS:528:DC%2BD3cXmsVaiu7c%3D 10969791
36. M Michaelis HW Doerr J Cinatl Jr 2009 Oncomodulation by human cytomegalovirus: evidence becomes stronger Med Microbiol Immunol 198 79 81 10.1007/s00430-009-0107-8 19198878
37. H Martin M Mandron C Davrinche 2008 Interplay between human cytomegalovirus and dendritic cells in T cell activation Med Microbiol Immunol 197 179 184 10.1007/s00430-008-0079-0 18264717
38. EC Waller E Day JG Sissons MR Wills 2008 Dynamics of T cell memory in human cytomegalovirus infection Med Microbiol Immunol 197 83 96 10.1007/s00430-008-0082-5 18301918
39. BY Su CY Su SF Yu CJ Chen 2007 Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity Med Microbiol Immunol 196 165 170 10.1007/s00430-007-0040-7 17318574 (Pubitemid 47300254)